Wallroth Donald E.

USNatural personCFO

Transactions

Issuers

Buys / Sells

0/2

Last tx

28 Sept 2009

USNatural personCFO

Transactions

Issuers

Buys / Sells

0/2

Last tx

28 Sept 2009

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Molecular Insight Pharmaceuticals, Inc.	0	reported	28 Sept 2009	tx 20+277,500−57,500

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
22 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.93 USD
28 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	13,500	3.93 USD
22 Aug 2009	OTHER	Molecular Insight Pharmaceuticals, Inc.	13,500	0.00 USD
23 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.93 USD
25 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.93 USD
18 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	8,000	3.93 USD
24 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.93 USD
22 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	0.00 USD	deriv
23 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	0.00 USD	deriv
18 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	8,000	0.00 USD	deriv
28 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	13,500	0.00 USD	deriv
24 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	0.00 USD	deriv
25 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	0.00 USD	deriv
22 May 2009	SALE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.80 USD
22 May 2009	SALE	Molecular Insight Pharmaceuticals, Inc.	2,500	3.75 USD
12 May 2009	GRANT_AWARD	Molecular Insight Pharmaceuticals, Inc.	30,000	0.00 USD	deriv
12 May 2009	GRANT_AWARD	Molecular Insight Pharmaceuticals, Inc.	60,000	0.00 USD	deriv
20 May 2008	GRANT_AWARD	Molecular Insight Pharmaceuticals, Inc.	20,000	0.01 USD
06 May 2008	GRANT_AWARD	Molecular Insight Pharmaceuticals, Inc.	40,000	0.00 USD	deriv

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Molecular Insight Pharmaceuticals, Inc.	0	reported	28 Sept 2009	tx 20+277,500−57,500

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
22 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.93 USD
28 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	13,500	3.93 USD
22 Aug 2009	OTHER	Molecular Insight Pharmaceuticals, Inc.	13,500	0.00 USD
23 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.93 USD
25 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.93 USD
18 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	8,000	3.93 USD
24 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.93 USD
22 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	0.00 USD	deriv
23 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	0.00 USD	deriv
18 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	8,000	0.00 USD	deriv
28 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	13,500	0.00 USD	deriv
24 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	0.00 USD	deriv
25 Sept 2009	EXERCISE	Molecular Insight Pharmaceuticals, Inc.	4,000	0.00 USD	deriv
22 May 2009	SALE	Molecular Insight Pharmaceuticals, Inc.	4,000	3.80 USD
22 May 2009	SALE	Molecular Insight Pharmaceuticals, Inc.	2,500	3.75 USD
12 May 2009	GRANT_AWARD	Molecular Insight Pharmaceuticals, Inc.	30,000	0.00 USD	deriv
12 May 2009	GRANT_AWARD	Molecular Insight Pharmaceuticals, Inc.	60,000	0.00 USD	deriv
20 May 2008	GRANT_AWARD	Molecular Insight Pharmaceuticals, Inc.	20,000	0.01 USD
06 May 2008	GRANT_AWARD	Molecular Insight Pharmaceuticals, Inc.	40,000	0.00 USD	deriv